Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARCA biopharma

28.80
0.0000
Volume:- -
Turnover:688.27K
Market Cap:849.32M
PE:-57.85
High:28.80
Open:28.80
Low:28.80
Close:28.80
52wk High:28.80
52wk Low:1.56
Shares:29.49M
Float Shares:4.79M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4978
EPS(LYR):-0.3704
ROE:-20.05%
ROA:-14.35%
PB:26.07
PE(LYR):-77.76

Loading ...

Sep 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 13, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 27, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 24, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 10, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 09, 2024

Major Issues Report

Form 8-K - Current report